Chimerix Inc.

Chimerix Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
48.03 M
Public Float
36.77 M
Chimerix Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.37
Market Cap
$205.82 M
Shares Outstanding
51.07 M
Public Float
44.26 M

Profile

Address
2505 Meridian Parkway
Durham North Carolina 27713
United States
Employees -
Website http://www.chimerix.com
Updated 07/08/2019
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R.

Financials

View All

M. Michelle Berrey
President, Chief Executive Officer & Director
Martha J. Demski
Chairman